No androgen withdrawal syndrome for enzalutamide: a report of disease dynamics in the postchemotherapy setting

Eur Urol. 2014 Jan;65(1):258-9. doi: 10.1016/j.eururo.2013.09.036. Epub 2013 Sep 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Androgen Receptor Antagonists / adverse effects
  • Androgen Receptor Antagonists / therapeutic use*
  • Humans
  • Male
  • Phenylthiohydantoin / adverse effects
  • Phenylthiohydantoin / analogs & derivatives*
  • Phenylthiohydantoin / therapeutic use
  • Prostatic Neoplasms, Castration-Resistant / drug therapy*
  • Substance Withdrawal Syndrome / etiology*

Substances

  • Androgen Receptor Antagonists
  • Phenylthiohydantoin
  • enzalutamide